Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Cash flows from operating activities:
Net (loss) income	$ (3,489)	$ 1,556
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
Depreciation and amortization expense	94	22
Amortization of debt issuance costs	0	23
Amortization of operating of lease right-of-use assets	(6)	8
Loss on disposal of property, plant, and equipment	0	7
Loss on dissenting shareholders' liability	829	0
Principal reduction on operating lease liabilities	0	(8)
Share-based compensation	103	26
Deferred income taxes	(128)	0
Changes in operating assets and liabilities:
Accounts receivable	(21)	0
Materials and supplies	(53)	0
Operating right-of-use assets	20	0
Prepaid expenses and other assets	337	(305)
Accounts payable, accrued expenses, and other liabilities	914	220
Income taxes receivable	0	145
Operating lease liabilities	(7)	0
Cash provided by (used in) operating activities from discontinued operations	970	(525)
Net cash (used in) provided by operating activities	(437)	1,169
Cash flows from investing activities:
Cash paid for acquisition of Amplex	(18,332)	0
Payments for property, plant, and equipment	(369)	(13)
Proceeds from the disposal of property, plant, and equipment	5	0
Net cash provided by investing activities from discontinued operations	40,809	12,918
Net cash provided by investing activities	22,113	12,905
Cash flows from financing activities:
Cash used in financing activities from discontinued operations	0	(13,850)
Net cash used in financing activities	0	(13,850)
Net increase in cash and cash equivalents	21,676	224
Cash and cash equivalents, at the beginning of period	18,982	454
Cash and cash equivalents, the end of period	40,658	678
Supplemental disclosure of cash flow information:
Interest paid	0	567
Income taxes paid	0	0
Supplemental schedule of noncash financing activities:
Purchase of property, plant, and equipment included in accounts payable	$ 132	$ 0